Torsten Eich

Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden

Schain, Frida; Boissin, Constance; Laczik, Tamas; Fedeli, Stefano et al.

Part of Transfusion and apheresis science, 2023

• DOI for Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden
• Download full text (pdf) of Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden

Analysis of extracorporeal photopheresis within the frame of the WAA register

Blaha, M.; Berlin, G.; Audzijoniene, J.; Griskevicius, A. et al.

Part of Transfusion and apheresis science, 2021

• DOI for Analysis of extracorporeal photopheresis within the frame of the WAA register
• Download full text (pdf) of Analysis of extracorporeal photopheresis within the frame of the WAA register

Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis

Stegmayr, Bernd; Newman, Elizabeth; Witt, Volker; Derfler, Kurt et al.

Part of Transfusion Medicine and Hemotherapy, p. 234-239, 2021

• DOI for Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis

Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.

Lorant, Tomas; Bengtsson, Mats; Eich, Torsten; Eriksson, Britt-Marie et al.

Part of American Journal of Transplantation, p. 2752-2762, 2018

• DOI for Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.
• Download full text (pdf) of Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.

Calcium: A Crucial Potentiator for Efficient Enzyme Digestion of the Human Pancreas

Eich, Torsten; Ståhle, Magnus U.; Gustafsson, Bengt; Horneland, Rune et al.

Part of Cell Transplantation, p. 1031-1038, 2018

• DOI for Calcium: A Crucial Potentiator for Efficient Enzyme Digestion of the Human Pancreas
• Download full text (pdf) of Calcium: A Crucial Potentiator for Efficient Enzyme Digestion of the Human Pancreas

Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden

Schain, Frida; Boissin, Constance; Laczik, Tamas; Fedeli, Stefano et al.

Part of Transfusion and apheresis science, 2023

• DOI for Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden
• Download full text (pdf) of Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden

Analysis of extracorporeal photopheresis within the frame of the WAA register

Blaha, M.; Berlin, G.; Audzijoniene, J.; Griskevicius, A. et al.

Part of Transfusion and apheresis science, 2021

• DOI for Analysis of extracorporeal photopheresis within the frame of the WAA register
• Download full text (pdf) of Analysis of extracorporeal photopheresis within the frame of the WAA register

Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.

Lorant, Tomas; Bengtsson, Mats; Eich, Torsten; Eriksson, Britt-Marie et al.

Part of American Journal of Transplantation, p. 2752-2762, 2018

• DOI for Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.
• Download full text (pdf) of Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.

Calcium: A Crucial Potentiator for Efficient Enzyme Digestion of the Human Pancreas

Eich, Torsten; Ståhle, Magnus U.; Gustafsson, Bengt; Horneland, Rune et al.

Part of Cell Transplantation, p. 1031-1038, 2018

• DOI for Calcium: A Crucial Potentiator for Efficient Enzyme Digestion of the Human Pancreas
• Download full text (pdf) of Calcium: A Crucial Potentiator for Efficient Enzyme Digestion of the Human Pancreas

Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment

Pauzuolis, Mindaugas; Eich, Torsten; Burman, Joachim

Part of PLOS ONE, 2017

• DOI for Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment
• Download full text (pdf) of Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment

IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.

Jordan, Stanley C; Lorant, Tomas; Choi, Jua; Kjellman, Christian et al.

Part of New England Journal of Medicine, p. 442-453, 2017

• DOI for IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.

Positron Emission Tomography to assess the outcome of intraportal islet transplantation

Eriksson, Olof; Selvaraju, Ramkumar; Eich, Torsten; Willny, Mariam et al.

Part of Diabetes, p. 2482-2489, 2016

• DOI for Positron Emission Tomography to assess the outcome of intraportal islet transplantation

Rapid desensitisation of anti-HLA antibodies using the IgG degrading enzyme IdeS in sensitized patients with chronic kidney disease

Eich, Torsten; Lorant, Tomas; Eriksson, Britt-Marie; Winstedt, Lena et al.

Part of Tissue Antigens, p. 226-227, 2016

Rapid Desensitisation Of Anti-Hla Antibodies Using The Igg Degrading Enzyme Ides In Sensitised Patients With Chronic Kidney Disease

Eich, Torsten; Lorant, Tomas; Eriksson, Britt-Marie; Winstedt, Lena et al.

Part of HLA, p. 226-227, 2016

Rapid Removal Of Anti-Hla Antibodies In Immunized Patients Awaiting Renal Transplantation - A Dose Finding Study Of The Igg Degrading Enzyme Ides

Lorant, Tomas; Bengtsson, Mats; Biglarnia, Alireza; Eich, Torsten et al.

Part of Transplant International, p. 73-73, 2015

Distribution of adoptively transferred porcine T-lymphoblasts tracked by (18)F-2-fluoro-2-deoxy-D-glucose and position emission tomography

Eriksson, Olof; Sadeghi, Arian; Carlsson, Björn; Eich, Torsten et al.

Part of Nuclear Medicine and Biology, p. 827-833, 2011

• DOI for Distribution of adoptively transferred porcine T-lymphoblasts tracked by (18)F-2-fluoro-2-deoxy-D-glucose and position emission tomography

Positron emission tomography: A real-time tool to quantify early islet engraftment in a preclinical large animal model

Eich, Torsten; Eriksson, Olof; Sundin, Anders; Estrada, Sergio et al.

Part of Transplantation, p. 893-898, 2007

• DOI for Positron emission tomography: A real-time tool to quantify early islet engraftment in a preclinical large animal model

Visualization of early engraftment in clinical islet transplantation by positron-emission tomography

Eich, Torsten; Eriksson, Olof; Lundgren, Torbjörn

Part of New England Journal of Medicine, p. 2754-2755, 2007

No beneficial effect of two-layer storage compared with UW-storage on human islet isolation and transplantation

Caballero-Corbalán, José; Eich, Torsten; Lundgren, Torbjörn; Foss, Aksel et al.

Part of Transplantation, p. 864-869, 2007

• DOI for No beneficial effect of two-layer storage compared with UW-storage on human islet isolation and transplantation

Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis

Stegmayr, Bernd; Newman, Elizabeth; Witt, Volker; Derfler, Kurt et al.

Part of Transfusion Medicine and Hemotherapy, p. 234-239, 2021

• DOI for Using the World Apheresis Association Registry Helps to Improve the Treatment Quality of Therapeutic Apheresis